β-Fluorofentanyls Are pH-Sensitive Mu Opioid Receptor Agonists

被引:18
|
作者
Rosas, Ricardo, Jr. [1 ]
Huang, Xi-Ping [2 ]
Roth, Bryan L. [2 ,3 ]
Dockendorf, Chris [1 ]
机构
[1] Marquette Univ, Dept Chem, POB 1881, Milwaukee, WI 53201 USA
[2] Univ N Carolina, NIMH, Psychoact Drug Screening Program, Dept Pharmacol,Sch Med, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 09期
关键词
Mu opioid receptor agonist; fentanyl; fluorination; pH-sensitive; analgesic; cAMP; FLUORINE;
D O I
10.1021/acsmedchemlett.9b00335
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The concept recently postulated by Stein and co-workers (Science 2017, 355, 966) that mu opioid receptor (MOR) agonists possessing amines with attenuated basicity show pH-dependent activity and can selectively act at damaged, low pH tissues has been additionally supported by in vitro studies reported here. We synthesized and tested analogs of fentanyl possessing one or two fluorine atoms at the beta position of the phenethylamine side chain, with additional fluorines optionally added to the benzene ring of the side chain. These compounds were synthesized in 1 to 3 steps from commercial building blocks. The novel bis-fluorinated analog RR-49 showed superior pH sensitivity, with full efficacy relative to DAMGO, but with 19-fold higher potency (IC50) in a MOR cAMP assay at pH 6.5 versus 7.4. Such compounds hold significant promise as analgesics for inflammatory pain with reduced abuse potential.
引用
收藏
页码:1353 / 1356
页数:7
相关论文
共 50 条
  • [1] Discovery of Novel pH-Sensitive μ-Opioid Receptor Agonists as Potent Analgesics with Reduced Side Effects
    Wang, Zhen
    Li, Zong-Zheng
    Han, Xiao-Min
    Dong, Jing
    Yin, Ming-Yue
    Song, Jie
    Zhuang, Tao
    Wang, Yuan
    ACS MEDICINAL CHEMISTRY LETTERS, 2025, 16 (02): : 285 - 293
  • [2] Role of efficacy at the mu opioid receptor on the interactions between mu opioid receptor agonists and cannabinoid receptor agonists: antinociception and drug discrimination
    Maguire, David
    France, Charles
    FASEB JOURNAL, 2014, 28 (01):
  • [3] Irreversible and noncompetitive mu opioid receptor agonists
    Stahl, Edward
    Schmid, Cullen L.
    Acevedo-Canabal, Agnes
    Read, Cai
    Grim, Travis
    Kennedy, Nicole M.
    Bannister, Thomas D.
    Bohn, Laura M.
    FASEB JOURNAL, 2022, 36
  • [4] The Role of Efficacy on the Interaction Between Mu Opioid Receptor Agonists and Cannabinoid Receptor Agonists
    Maguire, David R.
    France, Charles P.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S566 - S566
  • [5] Abuse Potential of Biased Mu Opioid Receptor Agonists
    Negus, S. Stevens
    Freeman, Kevin B.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2018, 39 (11) : 916 - 919
  • [6] pH-Sensitive Fluorescent Dyes: Are They Really pH-Sensitive in Cells?
    Zhang, Xiao-Xiang
    Wang, Zhe
    Yue, Xuyi
    Ma, Ying
    Kiesewetter, Dale O.
    Chen, Xiaoyuan
    MOLECULAR PHARMACEUTICS, 2013, 10 (05) : 1910 - 1917
  • [7] Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl
    Maguire, David R.
    France, Charles P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 784 : 199 - 206
  • [8] The Role of Peripheral Opioid Receptors in the Development of Tolerance to Mu-Opioid Receptor Agonists
    Sears, Bryan
    Voight, Brett
    Jutkiewicz, Emily
    FASEB JOURNAL, 2021, 35
  • [9] Research and development of κ opioid receptor agonists and δ opioid receptor agonists
    Nagase, Hiroshi
    Saitoh, Akiyoshi
    PHARMACOLOGY & THERAPEUTICS, 2020, 205
  • [10] Interactions Between Mu Opioid Receptor Agonists in Rats Discriminating Fentanyl
    Flynn, Shawn
    France, Charles
    FASEB JOURNAL, 2021, 35